Tang et al. demonstrated that reduced expression of BRD4 via RNAi or its pharmacologic inhibition by JQ-1 resulted in decreased proliferation and tumor growth in SHH MB, reducing the expression of the glioma-associated oncogenes GLI1 and GLI2 (27). Here, GLI2 is linked to neoplasm.